Preventing clinically important deterioration with single-inhaler triple therapy in COPD

Clinically important deterioration (CID) is a novel composite end-point (lung function, health status, exacerbations) for assessing disease stability in patients with chronic obstructive pulmonary disease (COPD). We prospectively analysed CID in the FULFIL study. FULFIL (ClinicalTrials.gov NCT023451...

Full beskrivning

Sparad:
Bibliografiska uppgifter
I publikationen:ERJ Open Res
Huvudupphovsmän: Naya, Ian, Compton, Chris, Ismaila, Afisi S., Birk, Ruby, Brealey, Noushin, Tabberer, Maggie, Zhu, Chang-Qing, Lipson, David A., Criner, Gerard
Materialtyp: Artigo
Språk:Inglês
Publicerad: European Respiratory Society 2018
Ämnen:
Original Articles
Länkar:https://ncbi.nlm.nih.gov/pmc/articles/PMC6168763/
https://ncbi.nlm.nih.gov/pubmed/30302335
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1183/23120541.00047-2018
Taggar: Lägg till en tagg
Inga taggar, Lägg till första taggen!

Liknande verk